Compare CYRX & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | CIVB |
|---|---|---|
| Founded | 1999 | 1884 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.6M | 500.4M |
| IPO Year | 2008 | 2012 |
| Metric | CYRX | CIVB |
|---|---|---|
| Price | $8.05 | $22.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $12.94 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 341.9K | 69.5K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.15% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | 1.40 | ★ 2.04 |
| Revenue | ★ $176,177,000.00 | $19,123,000.00 |
| Revenue This Year | $9.71 | $15.24 |
| Revenue Next Year | $9.56 | $6.52 |
| P/E Ratio | ★ $4.99 | $11.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.63 | $17.47 |
| 52 Week High | $11.45 | $25.59 |
| Indicator | CYRX | CIVB |
|---|---|---|
| Relative Strength Index (RSI) | 37.26 | 37.22 |
| Support Level | $6.57 | $21.42 |
| Resistance Level | $8.45 | $24.51 |
| Average True Range (ATR) | 0.51 | 0.76 |
| MACD | 0.04 | -0.20 |
| Stochastic Oscillator | 25.71 | 21.22 |
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.